What is the current Autoimmune Disease Testing market size?

The current Autoimmune Disease Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Autoimmune Disease Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the major challenges facing the Autoimmune Disease Testing market?

Major challenges include high costs of testing and limited awareness of autoimmune diseases in developing regions.

Which regions are expected to lead the Autoimmune Disease Testing market?

North America and Europe are expected to lead the market due to high awareness and advanced healthcare infrastructure.

Who are the top companies in the Autoimmune Disease Testing market?

Top companies include Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, among others.

What future opportunities exist in the Autoimmune Disease Testing market?

Future opportunities include the development of point-of-care testing and emerging markets with growing demand.

How will technology impact the Autoimmune Disease Testing market?

Advances in technologies like PCR and next-generation sequencing will drive the market forward with improved diagnostic accuracy.

What is the current regulatory landscape for the Autoimmune Disease Testing market?

The regulatory landscape is governed by strict guidelines from FDA and CE marking, ensuring safety and efficacy of testing products.

What is the future outlook for the Autoimmune Disease Testing market?

The future outlook is positive, with increasing adoption of autoimmune disease testing driving market growth and expansion.

Autoimmune Disease Testing Market Potential & Strategic Outlook 2033

Autoimmune Disease Testing by Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma, Vasculitis, Other), by Types (Instrument, Reagent Consumables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Autoimmune Disease Testing Market Overview

The Autoimmune Disease Testing market refers to the industry that provides diagnostic tests for autoimmune diseases, which are conditions where the body's immune system mistakenly attacks its own cells. As the Autoimmune Disease Testing market size is estimated to be around $3.8 billion, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses various testing methods, including enzyme-linked immunosorbent assay (ELISA), western blot, and immunofluorescence assays, which are used to diagnose conditions such as rheumatoid arthritis, lupus, and type 1 diabetes. The current market size is approximately $3.8 billion, with a forecasted growth rate of 8.5% CAGR from 2026 to 2033, driven by macro drivers such as the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.

Loading chart…

Key forces shaping the industry include technology shifts towards more sensitive and specific diagnostic tests, regulations such as the increasing need for regulatory approvals, and consumer behavior with a growing demand for early disease diagnosis. The largest region in the Autoimmune Disease Testing market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing awareness of autoimmune diseases and the rising demand for diagnostic tests. Overall, the Autoimmune Disease Testing market is expected to experience significant growth, driven by the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies, making it an attractive industry for investors and companies looking to expand their presence in the healthcare and diagnostics sectors.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	F. Hoffmann-La Roche Ltd; ZEus Scientific, Inc.; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Abbott; Ql Diagnostics Inc; Werfen; Trinity Biotech; KsL Beutner Laboratories (Beutner); Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Autoimmune Disease Testing market is poised for significant growth, driven by increasing awareness and advancements in diagnostic technologies. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and shifting demand patterns.

Growth Drivers2 items

Advances in immunological assays and multiplex technologies are enhancing the accuracy and efficiency of autoimmune disease testing, thereby driving the Autoimmune Disease Testing market size.

The growth forecast for the Autoimmune Disease Testing market is also fueled by the rising prevalence of autoimmune diseases, such as rheumatoid arthritis and lupus, which is increasing the demand for diagnostic tests.

Restraints2 items

High costs associated with autoimmune disease testing, particularly for specialized and proprietary tests, may hinder the adoption of these tests in resource-constrained settings, limiting the Autoimmune Disease Testing market size.

Stringent regulatory requirements and reimbursement challenges may also restrain the growth of the Autoimmune Disease Testing market, as manufacturers must navigate complex approval processes and negotiate with payers.

Opportunities2 items

The increasing adoption of point-of-care testing and digital health platforms presents opportunities for the Autoimmune Disease Testing market to expand its reach and improve patient outcomes.

Emerging markets, such as Asia-Pacific and Latin America, offer significant growth potential for the Autoimmune Disease Testing market, driven by rising healthcare spending and growing demand for diagnostic services.

Challenges2 items

The Autoimmune Disease Testing market faces challenges related to standardization and harmonization of testing protocols, which can lead to variability in test results and interpretation.

The market must also address concerns around data privacy and security, as the use of electronic health records and digital platforms becomes more widespread, impacting the growth forecast of the Autoimmune Disease Testing market.

Market Segmentation

Loading chart…

The Application segment in the Autoimmune Disease Testing market refers to the various uses of testing products and services. This includes diagnosis, treatment monitoring, and disease management. The application segment contributes significantly to the overall market size, as it encompasses a wide range of autoimmune diseases, such as rheumatoid arthritis, lupus, and thyroid disorders. Understanding the Autoimmune Disease Testing segmentation is crucial for industry players to develop targeted products and services, ultimately driving market growth.

The Types segment in the Autoimmune Disease Testing market is further divided into subtypes, including immunofluorescence assays, immunoblot assays, and multiplex immunoassays. Each subtype has its own unique characteristics, advantages, and limitations. For instance, immunofluorescence assays are widely used for diagnosing autoimmune diseases, while multiplex immunoassays offer high-throughput capabilities. Analyzing the market taxonomy of the Autoimmune Disease Testing market, including the types segment, is essential for companies to identify areas of opportunity and develop innovative products that cater to specific customer needs.

Autoimmune Disease Testing Segmentation Breakdown9 items

Application

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Scleroderma

Vasculitis

Other

Types

Instrument

Reagent Consumables

Regional Insights

Loading chart…

The Autoimmune Disease Testing market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The regional forecast indicates that Asia Pacific will be the fastest-growing region, driven by increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and rising investments in research and development.

Key drivers for each region include: North America - demographics with an aging population, infrastructure with well-established healthcare systems, and ecosystem maturity with a high concentration of major market players; Europe - adoption of personalized medicine, policies supporting public-private partnerships, and investments in digital health; Asia Pacific - demographics with a large and growing population, infrastructure development in emerging economies, and ecosystem maturity with increasing collaboration between industry and academia; Latin America - adoption of diagnostic technologies, policies supporting healthcare access, and investments in healthcare infrastructure; Middle East & Africa - demographics with a growing population, infrastructure development in emerging markets, and ecosystem maturity with increasing investment in healthcare.

Competitive Landscape

The Autoimmune Disease Testing market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Autoimmune Disease Testing competitive landscape is characterized by high competition, with players focusing on differentiation through technology, service models, and channel strength. Companies are employing various strategies to gain a competitive edge, including regional expansion, partnerships, and innovation pipelines.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can impact their ability to differentiate and maintain a competitive position. To address these challenges, companies are focusing on strategic initiatives that drive growth and profitability.

F. Hoffmann-La Roche Ltd: regional expansion

ZEus Scientific, Inc.: innovation pipeline

Thermo Fisher Scientific Inc.: premium pricing

Quest Diagnostics Incorporated: vertical integration

Abbott: OEM tie-ups

Bio-Rad Laboratories: local manufacturing

Key Autoimmune Disease Testing Companies10 items

F. Hoffmann-La Roche Ltd

ZEus Scientific, Inc.

Thermo Fisher Scientific Inc.

Quest Diagnostics Incorporated

Abbott

Ql Diagnostics Inc

Werfen

Trinity Biotech

KsL Beutner Laboratories (Beutner)

Bio-Rad Laboratories

Market Ecosystem

The Autoimmune Disease Testing ecosystem spans across upstream, midstream, and downstream segments, involving various stakeholders who contribute to the development, manufacturing, and delivery of testing solutions. Technology providers and suppliers form the upstream segment, while integrators and channels constitute the midstream. End users, including healthcare providers and patients, are the downstream segment. The value chain analysis of the Autoimmune Disease Testing ecosystem reveals how value is created and captured through the interactions among these stakeholders.

Raw material/component suppliers — provide reagents and equipment

Technology providers — develop testing platforms and assays

OEMs / manufacturers — produce testing instruments and kits

Distributors / channel partners — supply testing products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish testing standards and guidelines

End users / buyers — utilize testing solutions for diagnostic purposes

The flow of value in the Autoimmune Disease Testing ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact the adoption of testing solutions. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem's dynamics can differ by region, with varying regulatory frameworks, healthcare systems, and market demands shaping the interactions among stakeholders.

Recent Industry Insights

The Autoimmune Disease Testing industry has witnessed significant developments over the last 12-18 months, shaping Autoimmune Disease Testing industry trends. Recent partnerships, such as collaborative efforts between pharmaceutical companies and diagnostic firms, have accelerated the development of novel testing solutions. Notable mergers and acquisitions have also taken place, leading to consolidation and expansion of product portfolios. Furthermore, several companies have launched innovative products and technologies, enhancing the accuracy and efficiency of autoimmune disease diagnosis.

Additionally, regulatory changes have influenced the industry, with updated guidelines and standards for testing and diagnosis. A shift in consumer trends towards preventive care and personalized medicine has also driven demand for advanced autoimmune disease testing solutions. Moreover, funding rounds and expansions have enabled companies to invest in research and development, fueling innovation and growth in the Autoimmune Disease Testing market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Autoimmune Disease Testing market outlook. The market exhibits a high level of attractiveness due to the increasing prevalence of autoimmune diseases and the growing need for accurate diagnosis. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook is promising, driven by advancements in technology and the rising demand for personalized medicine.

The innovation landscape is characterized by the development of novel biomarkers, point-of-care testing, and artificial intelligence-powered diagnostic platforms. The demand-supply balance is expected to be stable, with manufacturers investing in capacity expansion to meet the growing demand. Key risk factors include regulatory changes, reimbursement pressures, and the emergence of new competitors. Overall, the Autoimmune Disease Testing market is poised for significant growth, driven by innovative solutions and increasing awareness about autoimmune diseases.

11 items

1. Executive Summary

2. Autoimmune Disease Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Autoimmune Disease Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Autoimmune Disease Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Rheumatoid Arthritis

6.1.2. Systemic Lupus Erythematosus

6.1.3. Scleroderma

6.1.4. Vasculitis

6.1.5. Other

6.2. Global Autoimmune Disease Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Instrument

6.2.2. Reagent Consumables

6.3. Global Autoimmune Disease Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Autoimmune Disease Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Autoimmune Disease Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Autoimmune Disease Testing Market Competition by Key Manufacturers

8.1. Global Autoimmune Disease Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Autoimmune Disease Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. F. Hoffmann-La Roche Ltd

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ZEus Scientific, Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Thermo Fisher Scientific Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Quest Diagnostics Incorporated

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Abbott

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Ql Diagnostics Inc

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Werfen

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Trinity Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. KsL Beutner Laboratories (Beutner)

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bio-Rad Laboratories

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Autoimmune Disease Testing Market

Figure 4: Global Autoimmune Disease Testing Market: Drivers

Figure 5: Global Autoimmune Disease Testing Market: Challenges

Figure 6: Global Autoimmune Disease Testing Market: Trends

Figure 7: Global Autoimmune Disease Testing Market: Opportunity

Figure 8: Global Autoimmune Disease Testing Market: Restraint

Figure 9: Global Autoimmune Disease Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Autoimmune Disease Testing Market Value (USD Million) By Region

Figure 15: Global Autoimmune Disease Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Autoimmune Disease Testing Market Value (USD Million) By Region

Figure 23: Global Autoimmune Disease Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Autoimmune Disease Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Autoimmune Disease Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Autoimmune Disease Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Autoimmune Disease Testing Market Value (USD Million) By Region

Table 10: Global Autoimmune Disease Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Autoimmune Disease Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Autoimmune Disease Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Autoimmune Disease Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: F. Hoffmann-La Roche Ltd Basic Information And Sales Area

Table 31: F. Hoffmann-La Roche Ltd. Products Portfolio

Table 32: ZEus Scientific, Inc. Basic Information And Sales Area

Table 33: ZEus Scientific, Inc.. Products Portfolio

Table 34: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 35: Thermo Fisher Scientific Inc.. Products Portfolio

Table 36: Quest Diagnostics Incorporated Basic Information And Sales Area

Table 37: Quest Diagnostics Incorporated. Products Portfolio

Table 38: Abbott Basic Information And Sales Area

Table 39: Abbott. Products Portfolio

Table 40: Ql Diagnostics Inc Basic Information And Sales Area

Table 41: Ql Diagnostics Inc. Products Portfolio

Table 42: Werfen Basic Information And Sales Area

Table 43: Werfen. Products Portfolio

Table 44: Trinity Biotech Basic Information And Sales Area

Table 45: Trinity Biotech. Products Portfolio

Table 46: KsL Beutner Laboratories (Beutner) Basic Information And Sales Area

Table 47: KsL Beutner Laboratories (Beutner). Products Portfolio

Table 48: Bio-Rad Laboratories Basic Information And Sales Area

Table 49: Bio-Rad Laboratories. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Autoimmune Disease Testing Market Value (USD Million) By Region

Table 55: Global Autoimmune Disease Testing Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Autoimmune Disease Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	F. Hoffmann-La Roche Ltd; ZEus Scientific, Inc.; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Abbott; Ql Diagnostics Inc; Werfen; Trinity Biotech; KsL Beutner Laboratories (Beutner); Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

The Autoimmune Disease Testing market faces challenges related to standardization and harmonization of testing protocols, which can lead to variability in test results and interpretation.

Market Segmentation

Loading chart…

Autoimmune Disease Testing Segmentation Breakdown9 items

Application

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Scleroderma

Vasculitis

Other

Types

Instrument

Reagent Consumables

Regional Insights

Loading chart…

Competitive Landscape

F. Hoffmann-La Roche Ltd: regional expansion

ZEus Scientific, Inc.: innovation pipeline

Thermo Fisher Scientific Inc.: premium pricing

Quest Diagnostics Incorporated: vertical integration

Abbott: OEM tie-ups

Bio-Rad Laboratories: local manufacturing

Key Autoimmune Disease Testing Companies10 items

F. Hoffmann-La Roche Ltd

ZEus Scientific, Inc.

Thermo Fisher Scientific Inc.

Quest Diagnostics Incorporated

Abbott

Ql Diagnostics Inc

Werfen

Trinity Biotech

KsL Beutner Laboratories (Beutner)

Bio-Rad Laboratories

Market Ecosystem

Raw material/component suppliers — provide reagents and equipment

Technology providers — develop testing platforms and assays

OEMs / manufacturers — produce testing instruments and kits

Distributors / channel partners — supply testing products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish testing standards and guidelines

End users / buyers — utilize testing solutions for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents